Response Rates And Quality Of Life Outcomes In Australasian Leukaemia & Lymphoma Group Nhl29: A Phase Ii Study Of Ibrutinib, Rituximab And Mini-Chop In Very Elderly Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma

BLOOD(2019)

引用 1|浏览22
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要